[S,S]-Reboxetine Dose-Range Finding Trial

RN624 For Pain Of Post-Herpetic Neuralgia

NCT00568321 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak

NCT00506610 ·Status: WITHDRAWN ·Phase: PHASE2

A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury

NCT06091020 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

NCT01058642 ·Status: TERMINATED ·Phase: PHASE2

Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia

NCT00099528 ·Status: UNKNOWN ·Phase: PHASE2

Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)

NCT00592774 ·Status: COMPLETED ·Phase: PHASE2

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

NCT00861068 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia

NCT04662281 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain

NCT01264237 ·Status: UNKNOWN ·Phase: PHASE4

Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia

NCT00809679 ·Status: TERMINATED ·Phase: PHASE2

Treatment of Pain Associated With Fibromyalgia

NCT02146430 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain

NCT01463397 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Etoricoxib on Peripheral Hyperalgesia

NCT01088256 ·Status: TERMINATED ·Phase: PHASE2

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NCT00002160 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

NCT00283842 ·Status: TERMINATED ·Phase: PHASE3

Evolution of Pain From Herpes Zoster

NCT00305357 ·Status: COMPLETED

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

NCT06568042 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

NCT05721287 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

NCT05096494 ·Status: COMPLETED ·Phase: PHASE2

Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component

NCT01166048 ·Status: COMPLETED ·Phase: PHASE4

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

NCT00390845 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

NCT03787004 ·Status: COMPLETED ·Phase: PHASE1

DS-5565 Phase III Study for Post-herpetic Neuralgia

NCT02318719 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia

NCT01318226 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT03219320 ·Status: COMPLETED ·Phase: PHASE2